DrugPatentWatch Database Preview

COMBIVIR Drug Profile

« Back to Dashboard

Which patents cover Combivir, and what generic alternatives are available?

Combivir is a drug marketed by Viiv Hlthcare and is included in one NDA.

The generic ingredient in COMBIVIR is lamivudine; zidovudine. There are twenty-nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the lamivudine; zidovudine profile page.

Summary for COMBIVIR

US Patents:	0
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	13
Clinical Trials:	61
Patent Applications:	2
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for COMBIVIR
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for COMBIVIR
DailyMed Link:	COMBIVIR at DailyMed

See drug prices for COMBIVIR

Recent Clinical Trials for COMBIVIR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Massachusetts General Hospital	Phase 2
AIDS Clinical Trials Group	Phase 3
GlaxoSmithKline	Phase 1

See all COMBIVIR clinical trials

Recent Litigation for COMBIVIR

Identify potential future generic entrants

District Court Litigation

Case Name	Date
Glaxo Group Ltd. v. Lupin Ltd.	2008-08-29
Plaintiff(s) v. Defendant(s)	2008-01-31
Glaxo Group Ltd. v. Teva Pharmaceuticals USA Inc.	2007-11-02

See all COMBIVIR litigation

Pharmacology for COMBIVIR

Drug Class	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Mechanism of Action	Nucleoside Reverse Transcriptase Inhibitors

Synonyms for COMBIVIR

[[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate

[[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate

1-(3'-Azido-2',3'-dideoxy-beta-D-xylofuranosyl)thymine 5'-triphosphate

3'-Azido-2',3'-dideoxythymidine-5'- triphosphate

3'-Azido-2',3'-dideoxythymidine-5'-triphosphate

3'-azido-3'-deoxythymidine 5'-(tetrahydrogen triphosphate)

3'-Azido-3'-deoxythymidine 5'-triphosphate

3'-azido-3'-deoxythymidine triphosphate

3'-Azido-dTTP

3'-Azidothymidine triphosphate

3'-Deoxy-3'-azidothymidine triphosphate

3'-N3-dTTP

6RGF96R053

92586-35-1

AC1L2HLG

AC1Q6S2D

AZddTTP

AZT triphosphate

Azt-TP

AZT-triphospate

AZTTP

BDBM50370476

CHEMBL193952

CTK5H1433

Dttp(3'N3)

DTXSID80239053

Erythro-azt-TP

FT-0615084

GLWHPRRGGYLLRV-XLPZGREQSA-N

LS-178176

N3dTTP

NSC742231

SCHEMBL19808965

Threo-azt-TP

Thymidine 5'-(tetrahydrogen triphosphate), 3'-azido-2', 3'-dideoxy-

Thymidine 5'-(tetrahydrogen triphosphate), 3'-azido-3'-deoxy-

UNII-6RGF96R053

ZDV-TP

Zidovudine 5'-triphosphate

Zidovudine triphosphate

ZINC13455082

US Patents and Regulatory Information for COMBIVIR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Viiv Hlthcare	COMBIVIR	lamivudine; zidovudine	TABLET;ORAL	020857-001	Sep 26, 1997	AB	RX	Yes	Yes

Expired US Patents for COMBIVIR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Viiv Hlthcare	COMBIVIR	lamivudine; zidovudine	TABLET;ORAL	020857-001	Sep 26, 1997
Viiv Hlthcare	COMBIVIR	lamivudine; zidovudine	TABLET;ORAL	020857-001	Sep 26, 1997
Viiv Hlthcare	COMBIVIR	lamivudine; zidovudine	TABLET;ORAL	020857-001	Sep 26, 1997
Viiv Hlthcare	COMBIVIR	lamivudine; zidovudine	TABLET;ORAL	020857-001	Sep 26, 1997
Viiv Hlthcare	COMBIVIR	lamivudine; zidovudine	TABLET;ORAL	020857-001	Sep 26, 1997
Viiv Hlthcare	COMBIVIR	lamivudine; zidovudine	TABLET;ORAL	020857-001	Sep 26, 1997